E78.49 is a specific clinical classification used for lipid disorders that are characterized by abnormally elevated levels of lipids (fats) in the blood but do not meet the criteria for pure hypercholesterolemia or mixed hyperlipidemia. This code is frequently used for conditions such as Familial Combined Hyperlipidemia (FCHL) or other complex dyslipidemias that involve varied elevations of low-density lipoprotein (LDL) and triglycerides. Managing these levels is critical as persistent hyperlipidemia is a major driver of [Atherosclerosis](/icd10/i70) and subsequent [Coronary Artery Disease](/icd10/i25-10). Clinical management focuses on reducing cardiovascular risk through a combination of pharmacological interventions, such as statins or fibrates, and aggressive lifestyle modifications. Providers must differentiate this from [Mixed Hyperlipidemia](/icd10/e78-2) to ensure the most accurate diagnostic representation. Monitoring for metabolic comorbidities like [Type 2 Diabetes](/icd10/e11-9) is standard practice, as these conditions often exacerbate lipid abnormalities.